Analysed HUTCHMED CHINA-ADR (HCM:NASDAQ) News Sources
HUTCHMED Initiates Global Trial of KRAS-EGFR-Antibody Conjugate Therapy HMPL-A830 in Patients with Solid Tumors
28-09-2026
yahoo.com
HUTCHMED Announces Submission of US NDA for ORPATHYS® plus TAGRISSO® in MET-Driven EGFR-Mutated Lung Cancer
29-09-2026
yahoo.com
HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
21-10-2026
yahoo.com
HUTCHMED Highlights SAFFRON Global Phase III Data Presented at ESMO Congress 2026 and Simultaneously Published in The New England Journal of Medicine
26-10-2026
yahoo.com
HUTCHMED Highlights SANOVO Phase III Data for ORPATHYS® plus TAGRISSO® in First-Line EGFR-Mutated Lung Cancer Presented at ESMO Congress 2026
26-10-2026
yahoo.com
What is the current price of HUTCHMED CHINA-ADR (HCM:NASDAQ)?
The current price of HUTCHMED CHINA-ADR (HCM:NASDAQ) is $13.8.
HUTCHMED CHINA-ADR (HCM:NASDAQ) absolute price change since previous trading day?
The absolute price change of HUTCHMED CHINA-ADR (HCM:NASDAQ) since the previous trading day is $-0.47.
HUTCHMED CHINA-ADR (HCM:NASDAQ) percentage price change since previous trading day?
The percentage price change of HUTCHMED CHINA-ADR (HCM:NASDAQ) since the previous trading day is -3.2936%.
What is the most recent average sentiment score for HUTCHMED CHINA-ADR (HCM:NASDAQ)?
The most recent average sentiment score for HUTCHMED CHINA-ADR (HCM:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for HUTCHMED CHINA-ADR (HCM:NASDAQ)?
The most recent sentiment for HUTCHMED CHINA-ADR (HCM:NASDAQ) is .
SEC-8K** Filing Available For HUTCHMED CHINA-ADR (HCM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.